Insider Transactions in Q2 2021 at Salarius Pharmaceuticals, Inc. (SLRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 03
2021
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,822
+9.26%
|
$0
$0.57 P/Share
|
|
May 03
2021
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
9,563
+26.68%
|
$0
$0.57 P/Share
|